Radcliffe Capital Management’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-267,376
Closed -$2.72M 970
2022
Q3
$2.72M Buy
267,376
+25,000
+10% +$253K 0.07% 504
2022
Q2
$2.44M Buy
242,376
+50,000
+26% +$502K 0.06% 593
2022
Q1
$1.93M Hold
192,376
0.04% 689
2021
Q4
$1.92M Buy
+192,376
New +$1.92M 0.05% 603

Other funds holding DTRT

Radcliffe Capital Management's DTRT Position: Q4 2022 in Review

Radcliffe Capital Management sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q4 2022, closing a stake of 267,376 shares — an estimated $2.72M sold.

Radcliffe Capital Management first reported a position in DTRT in Q4 2021 and held it in 4 quarters. The position peaked at $2.72M in Q3 2022. 17 funds tracked by Wall St. Rank hold DTRT as of Q4 2022.

  • Radcliffe Capital Management reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Radcliffe Capital Management sold 267,376 DTRT Health Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2.72M.
  • Radcliffe Capital Management first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 4 quarters.
  • Radcliffe Capital Management's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $2.72M in Q3 2022.
  • 17 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.